Serum iron levels in schizophrenic patients with or without akathisia

dc.contributor.authorKuloglu, M
dc.contributor.authorAtmaca, M
dc.contributor.authorÜstündag, B
dc.contributor.authorCanatan, H
dc.contributor.authorGecici, O
dc.contributor.authorTezcan, E
dc.date.accessioned2026-08-12T18:11:32Z
dc.date.issued2003
dc.departmentFırat Üniversitesi
dc.description.abstractThe pathophysiology of akathisia still remains controversial. Iron deficiency was proposed to be an important factor in the development of akathisia. In the present study, it was aimed to compare levels of serum iron and linked variables in chronic akathisic (n=30), and non-akathisic patients (n=30) with schizophrenia and healthy controls (n=30) because of the controversy in the association of iron and akathisia. The Barnes Akathisia Scale for akathisia and Simpson-Angus Rating Scale for extrapyramidal side effects were used. Serum iron and linked variables and hematological profile of the patients and control subjects were determined. Serum iron levels were significantly lower both in akathisic and non-akathisic groups compared to the control group (P<0.001). Moreover, akathisic patients had significantly lower iron levels than non-akathisic patients (P<0.05). Total iron binding capacity was significantly higher in patients with akathisia compared to the control group (P<0.01). Although non-akathisic patients had a mild increase in total iron binding capacity, it was not statistically significant compared to the control group (P>0.05). Ferritin levels were determined to be significantly lower in both groups compared to the control group (P<0.01). In addition, there was a significant difference in ferritin levels between the patients with and without akathisia (P<0.05). In conclusion, our results support the hypothesis that an association between akathisia and iron metabolism exists. (C) 2002 Elsevier Science B.V./ECNP All rights reserved.
dc.identifier.doi10.1016/S0924-977X(02)00073-1
dc.identifier.endpage71
dc.identifier.issn0924-977X
dc.identifier.issn1873-7862
dc.identifier.issue2
dc.identifier.orcid0000-0001-6621-2450
dc.identifier.pmid12650948
dc.identifier.startpage67
dc.identifier.urihttps://doi.org/10.1016/S0924-977X(02)00073-1
dc.identifier.urihttps://hdl.handle.net/11508/63717
dc.identifier.volume13
dc.identifier.wosWOS:000181908800002
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Neuropsychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectserum iron
dc.subjectakathisia
dc.subjectferritin
dc.subjecttotal iron binding capacity
dc.titleSerum iron levels in schizophrenic patients with or without akathisia
dc.typeArticle

Dosyalar